NGS-based RNA-sequencing Market - Global Outlook and Forecast 2022-2028

March 2022 | 106 pages | ID: N49C44486CE0EN
Market Monitor Global

Abstracts

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.

This report contains market size and forecasts of NGS-based RNA-sequencing in Global, including the following market information:

Global NGS-based RNA-sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global NGS-based RNA-sequencing market was valued at 1885.6 million in 2021 and is projected to reach US$ 5548.5 million by 2028, at a CAGR of 16.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sequencing by Synthesis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of NGS-based RNA-sequencing include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NGS-based RNA-sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global NGS-based RNA-sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global NGS-based RNA-sequencing Market Segment Percentages, by Type, 2021 (%)

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing

Global NGS-based RNA-sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global NGS-based RNA-sequencing Market Segment Percentages, by Application, 2021 (%)

• Research & Academia
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global NGS-based RNA-sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global NGS-based RNA-sequencing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies NGS-based RNA-sequencing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies NGS-based RNA-sequencing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Illumina
• Thermo Fischer Scientific
• Oxford Nanopore
• Agilent Technologies
• BGI
• PerkinElmer
• QIAGEN
• Eurofins Scientific
• Roche
• Takara Bio
• GENEWIZ
• Hamilton
• Macrogen
• Zymo Research
• Tecan Genomics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 NGS-based RNA-sequencing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global NGS-based RNA-sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NGS-BASED RNA-SEQUENCING OVERALL MARKET SIZE

2.1 Global NGS-based RNA-sequencing Market Size: 2021 VS 2028
2.2 Global NGS-based RNA-sequencing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top NGS-based RNA-sequencing Players in Global Market
3.2 Top Global NGS-based RNA-sequencing Companies Ranked by Revenue
3.3 Global NGS-based RNA-sequencing Revenue by Companies
3.4 Top 3 and Top 5 NGS-based RNA-sequencing Companies in Global Market, by Revenue in 2021
3.5 Global Companies NGS-based RNA-sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 NGS-based RNA-sequencing Players in Global Market
  3.6.1 List of Global Tier 1 NGS-based RNA-sequencing Companies
  3.6.2 List of Global Tier 2 and Tier 3 NGS-based RNA-sequencing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global NGS-based RNA-sequencing Market Size Markets, 2021 & 2028
  4.1.2 Sequencing by Synthesis
  4.1.3 Ion Semiconductor Sequencing
  4.1.4 Single-molecule Real-time Sequencing
  4.1.5 Nanopore Sequencing
4.2 By Type - Global NGS-based RNA-sequencing Revenue & Forecasts
  4.2.1 By Type - Global NGS-based RNA-sequencing Revenue, 2017-2022
  4.2.2 By Type - Global NGS-based RNA-sequencing Revenue, 2023-2028
  4.2.3 By Type - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global NGS-based RNA-sequencing Market Size, 2021 & 2028
  5.1.2 Research & Academia
  5.1.3 Hospitals & Clinics
  5.1.4 Pharmaceutical & Biotechnology Companies
  5.1.5 Others
5.2 By Application - Global NGS-based RNA-sequencing Revenue & Forecasts
  5.2.1 By Application - Global NGS-based RNA-sequencing Revenue, 2017-2022
  5.2.2 By Application - Global NGS-based RNA-sequencing Revenue, 2023-2028
  5.2.3 By Application - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global NGS-based RNA-sequencing Market Size, 2021 & 2028
6.2 By Region - Global NGS-based RNA-sequencing Revenue & Forecasts
  6.2.1 By Region - Global NGS-based RNA-sequencing Revenue, 2017-2022
  6.2.2 By Region - Global NGS-based RNA-sequencing Revenue, 2023-2028
  6.2.3 By Region - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America NGS-based RNA-sequencing Revenue, 2017-2028
  6.3.2 US NGS-based RNA-sequencing Market Size, 2017-2028
  6.3.3 Canada NGS-based RNA-sequencing Market Size, 2017-2028
  6.3.4 Mexico NGS-based RNA-sequencing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe NGS-based RNA-sequencing Revenue, 2017-2028
  6.4.2 Germany NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.3 France NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.4 U.K. NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.5 Italy NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.6 Russia NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.7 Nordic Countries NGS-based RNA-sequencing Market Size, 2017-2028
  6.4.8 Benelux NGS-based RNA-sequencing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia NGS-based RNA-sequencing Revenue, 2017-2028
  6.5.2 China NGS-based RNA-sequencing Market Size, 2017-2028
  6.5.3 Japan NGS-based RNA-sequencing Market Size, 2017-2028
  6.5.4 South Korea NGS-based RNA-sequencing Market Size, 2017-2028
  6.5.5 Southeast Asia NGS-based RNA-sequencing Market Size, 2017-2028
  6.5.6 India NGS-based RNA-sequencing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America NGS-based RNA-sequencing Revenue, 2017-2028
  6.6.2 Brazil NGS-based RNA-sequencing Market Size, 2017-2028
  6.6.3 Argentina NGS-based RNA-sequencing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa NGS-based RNA-sequencing Revenue, 2017-2028
  6.7.2 Turkey NGS-based RNA-sequencing Market Size, 2017-2028
  6.7.3 Israel NGS-based RNA-sequencing Market Size, 2017-2028
  6.7.4 Saudi Arabia NGS-based RNA-sequencing Market Size, 2017-2028
  6.7.5 UAE NGS-based RNA-sequencing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Illumina
  7.1.1 Illumina Corporate Summary
  7.1.2 Illumina Business Overview
  7.1.3 Illumina NGS-based RNA-sequencing Major Product Offerings
  7.1.4 Illumina NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.1.5 Illumina Key News
7.2 Thermo Fischer Scientific
  7.2.1 Thermo Fischer Scientific Corporate Summary
  7.2.2 Thermo Fischer Scientific Business Overview
  7.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Major Product Offerings
  7.2.4 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fischer Scientific Key News
7.3 Oxford Nanopore
  7.3.1 Oxford Nanopore Corporate Summary
  7.3.2 Oxford Nanopore Business Overview
  7.3.3 Oxford Nanopore NGS-based RNA-sequencing Major Product Offerings
  7.3.4 Oxford Nanopore NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.3.5 Oxford Nanopore Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies NGS-based RNA-sequencing Major Product Offerings
  7.4.4 Agilent Technologies NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.4.5 Agilent Technologies Key News
7.5 BGI
  7.5.1 BGI Corporate Summary
  7.5.2 BGI Business Overview
  7.5.3 BGI NGS-based RNA-sequencing Major Product Offerings
  7.5.4 BGI NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.5.5 BGI Key News
7.6 PerkinElmer
  7.6.1 PerkinElmer Corporate Summary
  7.6.2 PerkinElmer Business Overview
  7.6.3 PerkinElmer NGS-based RNA-sequencing Major Product Offerings
  7.6.4 PerkinElmer NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.6.5 PerkinElmer Key News
7.7 QIAGEN
  7.7.1 QIAGEN Corporate Summary
  7.7.2 QIAGEN Business Overview
  7.7.3 QIAGEN NGS-based RNA-sequencing Major Product Offerings
  7.7.4 QIAGEN NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.7.5 QIAGEN Key News
7.8 Eurofins Scientific
  7.8.1 Eurofins Scientific Corporate Summary
  7.8.2 Eurofins Scientific Business Overview
  7.8.3 Eurofins Scientific NGS-based RNA-sequencing Major Product Offerings
  7.8.4 Eurofins Scientific NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.8.5 Eurofins Scientific Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche NGS-based RNA-sequencing Major Product Offerings
  7.9.4 Roche NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 Takara Bio
  7.10.1 Takara Bio Corporate Summary
  7.10.2 Takara Bio Business Overview
  7.10.3 Takara Bio NGS-based RNA-sequencing Major Product Offerings
  7.10.4 Takara Bio NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.10.5 Takara Bio Key News
7.11 GENEWIZ
  7.11.1 GENEWIZ Corporate Summary
  7.11.2 GENEWIZ Business Overview
  7.11.3 GENEWIZ NGS-based RNA-sequencing Major Product Offerings
  7.11.4 GENEWIZ NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.11.5 GENEWIZ Key News
7.12 Hamilton
  7.12.1 Hamilton Corporate Summary
  7.12.2 Hamilton Business Overview
  7.12.3 Hamilton NGS-based RNA-sequencing Major Product Offerings
  7.12.4 Hamilton NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.12.5 Hamilton Key News
7.13 Macrogen
  7.13.1 Macrogen Corporate Summary
  7.13.2 Macrogen Business Overview
  7.13.3 Macrogen NGS-based RNA-sequencing Major Product Offerings
  7.13.4 Macrogen NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.13.5 Macrogen Key News
7.14 Zymo Research
  7.14.1 Zymo Research Corporate Summary
  7.14.2 Zymo Research Business Overview
  7.14.3 Zymo Research NGS-based RNA-sequencing Major Product Offerings
  7.14.4 Zymo Research NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.14.5 Zymo Research Key News
7.15 Tecan Genomics
  7.15.1 Tecan Genomics Corporate Summary
  7.15.2 Tecan Genomics Business Overview
  7.15.3 Tecan Genomics NGS-based RNA-sequencing Major Product Offerings
  7.15.4 Tecan Genomics NGS-based RNA-sequencing Revenue in Global Market (2017-2022)
  7.15.5 Tecan Genomics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. NGS-based RNA-sequencing Market Opportunities & Trends in Global Market
Table 2. NGS-based RNA-sequencing Market Drivers in Global Market
Table 3. NGS-based RNA-sequencing Market Restraints in Global Market
Table 4. Key Players of NGS-based RNA-sequencing in Global Market
Table 5. Top NGS-based RNA-sequencing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global NGS-based RNA-sequencing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global NGS-based RNA-sequencing Revenue Share by Companies, 2017-2022
Table 8. Global Companies NGS-based RNA-sequencing Product Type
Table 9. List of Global Tier 1 NGS-based RNA-sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NGS-based RNA-sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global NGS-based RNA-sequencing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - NGS-based RNA-sequencing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - NGS-based RNA-sequencing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global NGS-based RNA-sequencing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - NGS-based RNA-sequencing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - NGS-based RNA-sequencing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global NGS-based RNA-sequencing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global NGS-based RNA-sequencing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global NGS-based RNA-sequencing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America NGS-based RNA-sequencing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe NGS-based RNA-sequencing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia NGS-based RNA-sequencing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America NGS-based RNA-sequencing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa NGS-based RNA-sequencing Revenue, (US$, Mn), 2023-2028
Table 30. Illumina Corporate Summary
Table 31. Illumina NGS-based RNA-sequencing Product Offerings
Table 32. Illumina NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fischer Scientific Corporate Summary
Table 34. Thermo Fischer Scientific NGS-based RNA-sequencing Product Offerings
Table 35. Thermo Fischer Scientific NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 36. Oxford Nanopore Corporate Summary
Table 37. Oxford Nanopore NGS-based RNA-sequencing Product Offerings
Table 38. Oxford Nanopore NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies NGS-based RNA-sequencing Product Offerings
Table 41. Agilent Technologies NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 42. BGI Corporate Summary
Table 43. BGI NGS-based RNA-sequencing Product Offerings
Table 44. BGI NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 45. PerkinElmer Corporate Summary
Table 46. PerkinElmer NGS-based RNA-sequencing Product Offerings
Table 47. PerkinElmer NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 48. QIAGEN Corporate Summary
Table 49. QIAGEN NGS-based RNA-sequencing Product Offerings
Table 50. QIAGEN NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 51. Eurofins Scientific Corporate Summary
Table 52. Eurofins Scientific NGS-based RNA-sequencing Product Offerings
Table 53. Eurofins Scientific NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche NGS-based RNA-sequencing Product Offerings
Table 56. Roche NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 57. Takara Bio Corporate Summary
Table 58. Takara Bio NGS-based RNA-sequencing Product Offerings
Table 59. Takara Bio NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 60. GENEWIZ Corporate Summary
Table 61. GENEWIZ NGS-based RNA-sequencing Product Offerings
Table 62. GENEWIZ NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 63. Hamilton Corporate Summary
Table 64. Hamilton NGS-based RNA-sequencing Product Offerings
Table 65. Hamilton NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 66. Macrogen Corporate Summary
Table 67. Macrogen NGS-based RNA-sequencing Product Offerings
Table 68. Macrogen NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 69. Zymo Research Corporate Summary
Table 70. Zymo Research NGS-based RNA-sequencing Product Offerings
Table 71. Zymo Research NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)
Table 72. Tecan Genomics Corporate Summary
Table 73. Tecan Genomics NGS-based RNA-sequencing Product Offerings
Table 74. Tecan Genomics NGS-based RNA-sequencing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. NGS-based RNA-sequencing Segment by Type in 2021
Figure 2. NGS-based RNA-sequencing Segment by Application in 2021
Figure 3. Global NGS-based RNA-sequencing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global NGS-based RNA-sequencing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global NGS-based RNA-sequencing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2021
Figure 8. By Type - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 9. By Application - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 10. By Region - Global NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 11. By Country - North America NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 12. US NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 16. Germany NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 17. France NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 24. China NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 28. India NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 30. Brazil NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa NGS-based RNA-sequencing Revenue Market Share, 2017-2028
Figure 33. Turkey NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE NGS-based RNA-sequencing Revenue, (US$, Mn), 2017-2028
Figure 37. Illumina NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fischer Scientific NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Oxford Nanopore NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BGI NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. PerkinElmer NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. QIAGEN NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eurofins Scientific NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takara Bio NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GENEWIZ NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hamilton NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Macrogen NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Zymo Research NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Tecan Genomics NGS-based RNA-sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)